BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26739486)

  • 1. Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery.
    Campa MJ; Moody MA; Zhang R; Liao HX; Gottlin EB; Patz EF
    Cancer Immunol Immunother; 2016 Feb; 65(2):171-80. PubMed ID: 26739486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas.
    Nzula S; Going JJ; Stott DI
    Cancer Res; 2003 Jun; 63(12):3275-80. PubMed ID: 12810659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies.
    Zirakzadeh AA; Marits P; Sherif A; Winqvist O
    J Immunol; 2013 Jun; 190(11):5847-55. PubMed ID: 23630345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer.
    Yasuda M; Takenoyama M; Obata Y; Sugaya M; So T; Hanagiri T; Sugio K; Yasumoto K
    Cancer Res; 2002 Mar; 62(6):1751-6. PubMed ID: 11912150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
    Linette GP; Becker-Hapak M; Skidmore ZL; Baroja ML; Xu C; Hundal J; Spencer DH; Fu W; Cummins C; Robnett M; Kaabinejadian S; Hildebrand WH; Magrini V; Demeter R; Krupnick AS; Griffith OL; Griffith M; Mardis ER; Carreno BM
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23662-23670. PubMed ID: 31685621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human monoclonal antimelanoma single-chain Fv antibody derived from tumor-infiltrating lymphocytes.
    Zhang H; Lake DF; Barbuto JA; Bernstein RM; Grimes WJ; Hersh EM
    Cancer Res; 1995 Aug; 55(16):3584-91. PubMed ID: 7627967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors.
    Mantovani L; Wilder RL; Casali P
    J Immunol; 1993 Jul; 151(1):473-88. PubMed ID: 7686945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes.
    Kotlan B; Simsa P; Teillaud JL; Fridman WH; Toth J; McKnight M; Glassy MC
    J Immunol; 2005 Aug; 175(4):2278-85. PubMed ID: 16081796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation.
    Ikematsu H; Harindranath N; Ueki Y; Notkins AL; Casali P
    J Immunol; 1993 Feb; 150(4):1325-37. PubMed ID: 8432980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen.
    Mami-Chouaib F; Echchakir H; Dorothée G; Vergnon I; Chouaib S
    Immunol Rev; 2002 Oct; 188():114-21. PubMed ID: 12445285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast.
    Coronella JA; Spier C; Welch M; Trevor KT; Stopeck AT; Villar H; Hersh EM
    J Immunol; 2002 Aug; 169(4):1829-36. PubMed ID: 12165506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers.
    Shigematsu Y; Hanagiri T; Kuroda K; Baba T; Mizukami M; Ichiki Y; Yasuda M; Takenoyama M; Sugio K; Yasumoto K
    Cancer Sci; 2009 Jul; 100(7):1326-34. PubMed ID: 19432887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation of an intracellular antigen to the surface of medullary breast cancer cells early in apoptosis allows for an antigen-driven antibody response elicited by tumor-infiltrating B cells.
    Hansen MH; Nielsen HV; Ditzel HJ
    J Immunol; 2002 Sep; 169(5):2701-11. PubMed ID: 12193744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Repertoire Analysis of Tumor-Infiltrating B Cells Reveals Distinct Signatures and Distributions Across Tissues.
    Aizik L; Dror Y; Taussig D; Barzel A; Carmi Y; Wine Y
    Front Immunol; 2021; 12():705381. PubMed ID: 34349765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection.
    O'Brien PM; Tsirimonaki E; Coomber DW; Millan DW; Davis JA; Campo MS
    Cancer Immunol Immunother; 2001 Dec; 50(10):523-32. PubMed ID: 11776374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.
    Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
    Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-Presenting Intratumoral B Cells Affect CD4
    Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
    Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous CD4
    Veatch JR; Jesernig BL; Kargl J; Fitzgibbon M; Lee SM; Baik C; Martins R; Houghton AM; Riddell SR
    Cancer Immunol Res; 2019 Jun; 7(6):910-922. PubMed ID: 31043415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.